Osaic Holdings’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.5K Sell
484
-18
-4% -$1.3K ﹤0.01% 5647
2026
Q1
$34.2K Buy
502
+17
+4% +$1.2K ﹤0.01% 5489
2025
Q4
$36.8K Sell
485
-249
-34% -$18.1K ﹤0.01% 5451
2025
Q3
$38.1K Buy
734
+420
+134% +$21.9K ﹤0.01% 5487
2025
Q2
$15.3K Buy
314
+237
+308% +$11.3K ﹤0.01% 5897
2025
Q1
$3.92K Sell
77
-46
-37% -$2.29K ﹤0.01% 6294
2024
Q4
$5.55K Sell
123
-14
-10% -$599 ﹤0.01% 6133
2024
Q3
$5.08K Sell
137
-2
-1% -$67 ﹤0.01% 6186
2024
Q2
$4.25K Buy
139
+54
+64% +$1.75K ﹤0.01% 6251
2024
Q1
$2.47K Sell
85
-232
-73% -$6.5K ﹤0.01% 6388
2023
Q4
$8.73K Buy
317
+81
+34% +$1.85K ﹤0.01% 5905
2023
Q3
$5.29K Sell
236
-186
-44% -$6.92K ﹤0.01% 6251
2023
Q2
$17.1K Sell
422
-135
-24% -$6.61K ﹤0.01% 5674
2023
Q1
$27K Buy
557
+197
+55% +$9.01K ﹤0.01% 5387
2022
Q4
$14K Sell
360
-99
-22% -$4.12K ﹤0.01% 5771
2022
Q3
$23K Sell
459
-127
-22% -$6.22K ﹤0.01% 5479
2022
Q2
$23K Sell
586
-245
-29% -$8.59K ﹤0.01% 5521
2022
Q1
$31K Buy
831
+88
+12% +$3.39K ﹤0.01% 5423
2021
Q4
$29K Buy
743
+146
+24% +$5.59K ﹤0.01% 5526
2021
Q3
$22K Buy
597
+71
+13% +$2.92K ﹤0.01% 5705
2021
Q2
$22K Sell
526
-133
-20% -$5.7K ﹤0.01% 5605
2021
Q1
$32K Sell
659
-15
-2% -$891 ﹤0.01% 5192
2020
Q4
$41K Sell
674
-514
-43% -$30.3K ﹤0.01% 4698
2020
Q3
$55K Sell
1,188
-42
-3% -$2.07K ﹤0.01% 4232
2020
Q2
$62K Buy
1,230
+89
+8% +$4.37K ﹤0.01% 4039
2020
Q1
$51K Buy
+1,141
New +$57.4K ﹤0.01% 3957

Other funds holding PTCT

Osaic Holdings's PTCT Position: Q2 2026 in Review

Osaic Holdings reduced its PTC Therapeutics (PTCT) stake by 3.6% in Q2 2026, selling an estimated $1.3K and leaving 484 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5647.

Osaic Holdings first reported a position in PTCT in Q1 2020 and has held it in 26 quarters since. The position peaked at $62K in Q2 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Osaic Holdings held 484 shares of PTC Therapeutics worth $39.5K as of Q2 2026.
  • Osaic Holdings sold 18 PTC Therapeutics shares in Q2 2026, an estimated $1.3K.
  • PTC Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5647 holding.
  • Osaic Holdings first reported a position in PTC Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's PTC Therapeutics position peaked at $62K in Q2 2020.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.